Antimicrobial Susceptibility Testing Market Forecast 2026: Where the Industry Is Headed
Uncover key drivers, emerging technologies, and competitive movements shaping the antimicrobial susceptibility testing market from 2026–2035 with trusted insights from The Business Research Company
What level of CAGR-driven expansion is anticipated in the Antimicrobial Susceptibility Testing Market between 2026 and 2030?
The antimicrobial susceptibility testing market size has shown significant growth in recent years. This market is projected to expand from $4.65 billion in 2025 to $4.93 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.0%. The historical increase in this market can be attributed to factors such as a rising incidence of infectious diseases, increasing awareness regarding antimicrobial resistance, the expansion of clinical microbiology laboratories, a rise in hospital diagnostic testing volumes, and the availability of standardized AST protocols.
The antimicrobial susceptibility testing market is projected to experience substantial growth in the upcoming period. By 2030, its value is set to reach $6.01 billion, achieving a compound annual growth rate (CAGR) of 5.1%. This projected growth throughout the forecast period stems from several factors, including heightened investments in rapid diagnostic technologies, the increasing integration of AI-assisted laboratory analysis, broader expansion of antimicrobial resistance surveillance programs, a rising need for point-of-care AST solutions, and an intensified emphasis on precision antimicrobial therapy. Key trends expected during this period encompass the wider adoption of automated AST systems, an escalating demand for swift diagnostic testing, the deepening integration of molecular and phenotypic methodologies, further expansion of laboratory automation solutions, and a stronger focus on monitoring antimicrobial resistance.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4026&type=smp
What Drivers Are Affecting Demand-Supply Dynamics In The Antimicrobial Susceptibility Testing Market?
The worldwide increase in the prevalence of infectious diseases has contributed to the growth of the antimicrobial susceptibility testing market. Infectious diseases originate from organisms such as bacteria, viruses, fungi, and parasites. Examples include bacterial pneumonia, tuberculosis (bacterial), and viral conditions like smallpox, AIDS, among others. For instance, in March 2024, data from the Centers for Disease Control and Prevention, a US-based national public health agency, indicated that in 2023, out of 9,573 TB cases where birth origin was identified, 7,259 (76%) occurred among non-U.S.–born persons. This represented an 18% increase compared with the 6,177 such cases documented in 2022. Consequently, the rising incidence of infectious diseases is a key driver for the growth of the antimicrobial susceptibility testing market.
How Is The Antimicrobial Susceptibility Testing Market Organized Into Various Segments?
The antimicrobial susceptibility testing market covered in this report is segmented –
1) By Testing Type: Antibacterial Testing, Antifungal Testing, Antiparasitic Testing, Other Testing Types
2) By Product: Manual Antimicrobial Susceptibility Testing Products, Automated Laboratory Instruments, Consumables
3) By Application: Diagnostics, Drug Discovery and Development, Epidemiology, Other Applications
4) By End User: Hospitals And Diagnostic Centers, Pharmaceutical And Biotechnology Companies, Research And Academic Institutes, Clinical Research Organizations (CROs)
Subsegments:
1) By Antibacterial Testing: Disk Diffusion Method, Broth Dilution Method, E-Test Method, Automated Systems
2) By Antifungal Testing: Broth Dilution Method, Agar Disk Diffusion Method, E-Test Method, Colorimetric Methods
3) By Antiparasitic Testing: In vitro Susceptibility Testing, Microscopic Examination, Molecular Methods
4) By Other Testing Types: Mycobacterial Susceptibility Testing, Biofilm Susceptibility Testing, Combination Antimicrobial Testing
How Are New Market Trends Shaping The Landscape Of The Antimicrobial Susceptibility Testing Market?
Leading companies within the antimicrobial susceptibility testing market are creating innovative products, such as the First POC Testing System. This system identifies the presence or absence of bacteria and evaluates the effectiveness of antimicrobials using urine samples from patients suspected of having urinary tract infections (UTIs). It constitutes a significant advance in AST technologies, aiding in the quicker initiation of targeted antimicrobial therapy for patients with infections. For example, in June 2023, Sysmex Corporation, a Japan-based firm that produces reagents and equipment for clinical tests, including hematologic (blood) and immune assessments, unveiled a testing system for rapid antimicrobial susceptibility detection. Utilizing a unique and proprietary microfluidic technology, the system yields antimicrobial susceptibility testing (AST) results in as little as 30 minutes from the start of measurement, a notable improvement compared to the several days typically required for conventional AST.
Who Are The Primary Competitors In The Global Antimicrobial Susceptibility Testing Market?
Major companies operating in the antimicrobial susceptibility testing market are BioMérieux SA, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Danaher Corporation, Bio-Rad Laboratories Inc., Accelerate Diagnostics Inc., Alifax Holding S.p.A., Synbiosis Ltd., Mast Group Ltd., ELITechGroup, Genefluidics Inc., QuantaMatrix Inc., Bruker Corporation, Eurofins Scientific SE, Liofilchem s.r.l., Hardy Diagnostics, Bioanalyse GmbH, Lab M Limited, Microbiologics Inc., Quidel Corporation, R-Biopharm AG, SSI Diagnostica A/S
Access The Complete Report For Deeper Market Insights:
Which Global Regions Are Shaping The Competitive Landscape Of The Antimicrobial Susceptibility Testing Market?
North America was the largest region in the antimicrobial susceptibility testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the antimicrobial susceptibility testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Antimicrobial Susceptibility Testing Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=4026&type=smp
Browse Through More Reports Similar to the Global Antimicrobial Susceptibility Testing Market 2026, By The Business Research Company
Infectious Disease Diagnostics Testing Market Report 2026
Veterinary Antimicrobial Susceptibility Testing Market Report 2026
Gastrointestinal Pathogen Testing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
